logo
#

Latest news with #ENZB

Enzo Biochem: Fiscal Q3 Earnings Snapshot
Enzo Biochem: Fiscal Q3 Earnings Snapshot

Yahoo

time17-06-2025

  • Business
  • Yahoo

Enzo Biochem: Fiscal Q3 Earnings Snapshot

FARMINGDALE, N.Y. (AP) — FARMINGDALE, N.Y. (AP) — Enzo Biochem Inc. (ENZB) on Monday reported a loss of $2.8 million in its fiscal third quarter. On a per-share basis, the Farmingdale, New York-based company said it had a loss of 5 cents. Losses, adjusted to account for discontinued operations and non-recurring costs, were 4 cents per share. The life sciences and biotechnology company posted revenue of $6.4 million in the period. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ENZB at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Enzo Biochem: Fiscal Q3 Earnings Snapshot
Enzo Biochem: Fiscal Q3 Earnings Snapshot

Washington Post

time16-06-2025

  • Business
  • Washington Post

Enzo Biochem: Fiscal Q3 Earnings Snapshot

FARMINGDALE, N.Y. — FARMINGDALE, N.Y. — Enzo Biochem Inc. (ENZB) on Monday reported a loss of $2.8 million in its fiscal third quarter. On a per-share basis, the Farmingdale, New York-based company said it had a loss of 5 cents. Losses, adjusted to account for discontinued operations and non-recurring costs, were 4 cents per share. The life sciences and biotechnology company posted revenue of $6.4 million in the period. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ENZB at

Enzo Biochem: Fiscal Q3 Earnings Snapshot
Enzo Biochem: Fiscal Q3 Earnings Snapshot

Yahoo

time16-06-2025

  • Business
  • Yahoo

Enzo Biochem: Fiscal Q3 Earnings Snapshot

FARMINGDALE, N.Y. (AP) — FARMINGDALE, N.Y. (AP) — Enzo Biochem Inc. (ENZB) on Monday reported a loss of $2.8 million in its fiscal third quarter. On a per-share basis, the Farmingdale, New York-based company said it had a loss of 5 cents. Losses, adjusted to account for discontinued operations and non-recurring costs, were 4 cents per share. The life sciences and biotechnology company posted revenue of $6.4 million in the period. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ENZB at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store